AccuStem Sciences, Inc.
ACUT
$0.55
$0.1330.95%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 11.22% | 25.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.38% | 17.97% | |||
| Operating Income | -13.38% | -17.97% | |||
| Income Before Tax | -13.38% | -17.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.38% | -17.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.38% | -17.97% | |||
| EBIT | -13.38% | -17.97% | |||
| EBITDA | -13.41% | -18.03% | |||
| EPS Basic | -10.03% | -17.96% | |||
| Normalized Basic EPS | -9.94% | -18.30% | |||
| EPS Diluted | -10.03% | -17.96% | |||
| Normalized Diluted EPS | -9.94% | -18.30% | |||
| Average Basic Shares Outstanding | 3.13% | 0.00% | |||
| Average Diluted Shares Outstanding | 3.13% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||